Pipeline™ Vantage Embolization Device with Shield Technology™, Medtronic – Sim&Size v1.1.2
Under Clinical Trail : The purpose of this study is to assess the safety and effectiveness of the Pipeline™ Vantage Embolization Device with Shield Technology™ in the treatment of intracranial aneurysms within the intended indication for use.
Indication for Use
The Pipeline™ Vantage Embolization Device with Shield Technology™ is intended for endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms located in the internal carotid artery (up to the terminus).